To get your own Tarsier GIS booklet, please answer the following 4 questions and we will send it to your address:

*Until stock run out, and at Tarsier’s discretion*

Contact & Address details:
1. Please enter your contact details:
Survey Questions:
2. According to the literature, the prevalence of uveitic glaucoma is approximately 30% of all non-infectious anterior uveitis cases. What percentage of your uveitis patients are using anti-glaucoma medication and/or had a glaucoma procedure in the past?
3. From your experience, how does the following contribute to visual impairment and blindness in non-infectious anterior uveitis patients (1 – minimal contribution, 5 – high contribution)?
Glaucoma
Chronic Disease Course
Macular Edema
Cataract
Steroid Use
4. What are the primary factors, in your opinion, that are likely to drive the adoption of a new medication for treatment of anterior non-infectious uveitic flare-ups? (1 – minimal contribution, 5 – high contribution)
Efficacy
No IOP elevation
Better drug tolerability
Less frequent administration
Scroll to Top

THANK YOU

Thank you for your answers, we will send you soon your ACC GIS booklet! – Tarsier Pharma

Skip to content